Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [896]

OncoAlert Round Up for August 18th - 24th, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for August 18th - 24th, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

War in Ukraine: The Global Medical Knowledge Alliance's response to improving...

Prof Richard Sullivan, Asst. Prof Darya Kizub and Asst. Prof Nelya Melnitchouk

War in Ukraine: The Global Medical Knowledge Alliance's response to improving cancer care ( Prof Richard Sullivan, Asst. Prof Darya Kizub and Asst. Prof Nelya Melnitchouk )

Latest in immunological technologies that can treat, control, and prevent cancer

Dr Jill O’Donnell-Tormey - Chief Executive Officer, Cancer Research Institute

Latest in immunological technologies that can treat, control, and prevent cancer ( Dr Jill O’Donnell-Tormey - Chief Executive Officer, Cancer Research Institute )

Sudan: Conflict, cancer care, and ripple effects on the region

Dr Nazik Hammad - University of Toronto, Toronto, Canada

Sudan: Conflict, cancer care, and ripple effects on the region ( Dr Nazik Hammad - University of Toronto, Toronto, Canada )

Geriatric oncology in resource-limited settings

Dr Enrique Soto Perez de Celis - National Institute of Medical Sciences, Mexico...

Geriatric oncology in resource-limited settings ( Dr Enrique Soto Perez de Celis - National Institute of Medical Sciences, Mexico City, Mexico )

Tailored oncology for all breast cancer patients

Dr Didier Verhoeven, Prof Helena Earl and Prof Sabine Siesling

Tailored oncology for all breast cancer patients ( Dr Didier Verhoeven, Prof Helena Earl and Prof Sabine Siesling )

Rationale for routine use of IORT for early breast cancer and data for specific...

Dr Hans-Christian Kolberg - Marienhospital Bottrop gGmbH, Bottrop, Germany

Rationale for routine use of IORT for early breast cancer and data for specific indications ( Dr Hans-Christian Kolberg - Marienhospital Bottrop gGmbH, Bottrop, Germany )

Radiation therapy after radical surgery in prostate cancer

Dr Roberto Paz - Oncosalud - AUNA, Lima, Peru

Radiation therapy after radical surgery in prostate cancer ( Dr Roberto Paz - Oncosalud - AUNA, Lima, Peru )

FOLFOX with selective use of 5FUCRT is non-inferior to 5FUCRT for treatment of...

Dr Martin Weiser - Memorial Sloan Kettering Cancer Center, New York City, USA

FOLFOX with selective use of 5FUCRT is non-inferior to 5FUCRT for treatment of LARC prior to low anterior resection with TME ( Dr Martin Weiser - Memorial Sloan Kettering Cancer Center, New York City, USA )

Primary mediastinal B-cell lymphoma: Radiotherapy superfluous post...

Prof Emanuele Zucca - Oncology Institute of Southern Switzerland, Bellinzona...

Primary mediastinal B-cell lymphoma: Radiotherapy superfluous post-chemoimmunotherapy ( Prof Emanuele Zucca - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland )

Next-generation selective RET inhibitor shows initial promise with RET-altered...

Prof Qing Zhou - Guangdong Provincial People’s Hospital, Guangzhou, China

Next-generation selective RET inhibitor shows initial promise with RET-altered solid tumours ( Prof Qing Zhou - Guangdong Provincial People’s Hospital, Guangzhou, China )

Neoadjuvant chemo with mFOLFIRINOX shows survival benefit in locally advanced...

Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France

Neoadjuvant chemo with mFOLFIRINOX shows survival benefit in locally advanced rectal cancer ( Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France )

More from ecancer